Table 3 Included studies’ basic characteristics
From: Powered single hip joint exoskeletons for gait rehabilitation: a systematic review and Meta-analysis
N | Author (year) | Study type | Sample size | Condition | F/U (month) | Group (N) | Robot | Age | Sex ratio (female %) |
|---|---|---|---|---|---|---|---|---|---|
1 | Jayaraman (2018) | RCT | 50 | Chronic stroke | 3 | PSHJE (25) | SMA | 59.5 ± 9.7 | 36 |
No PSHJE (25) | 61.6 ± 12.6 | 32 | |||||||
2 | Kitatani (2014) | Single group clinical trial | 10 | Healthy | 0 | PSHJE | SMA | 24.4 ± 3.5 | 50 |
No PSHJE | |||||||||
3 | Koseki (2021) | NRCT | 22 | Knee arthroplasty | 2 | PSHJE (11) | HWA | 71.8 ± 6.2 | 100 |
No PSHJE (11) | 75.9 ± 6.9 | 90.9 | |||||||
4 | Ji (2018) | RCT | 16 | Hemiplegic | 2 | PSHJE (8) | RART | 48. 85 ± 20.9 | 43.75 |
No PSHJE (8) | |||||||||
5 | Kim (2018) | Single group clinical trial | 15 | Healthy elderly | 0 | PSHJE | GEMS | 74.33 ± 4.56 | 60 |
No PSHJE | |||||||||
6 | Kawasaki (2020) | Cross-over RCT | 10 | Spastic CP children | 0 | PSHJE | HWA (RAGT) | 11.1 ± 2.3 | 60 |
No PSHJE | |||||||||
7 | Hwang-Jae Lee (2016) | Single group clinical trial | 30 | Healthy elderly | 0 | PSHJE | GEMS | 74.07 ± 4.14 | 50 |
No PSHJE | |||||||||
8 | Su-Hyun Lee (2017) | Single group clinical trial | 30 | Healthy elderly | 0 | PSHJE | GEMS | 74.10 ± 4.18 | 53.3 |
No PSHJE | |||||||||
9 | Hwang-Jae Lee (2019) | RCT | 26 | Chronic stroke | 0 | PSHJE (14) | GEMS | 61.85 ± 7.87 | 50 |
No PSHJE (12) | 62.25 ± 6.36 | 41.6 | |||||||
10 | Lenzi (2013) | Single group clinical trial | 10 | Healthy | 0 | PSHJE | ALEX II | NI | NI |
No PSHJE | |||||||||
11 | Martini (2019) | RCT | 20 | Elderly | 1 | PSHJE (10) | APO | 70 ± 5 | 20 |
No PSHJE (10) | 70 ± 4 | 70 | |||||||
12 | Tanaka (2017) | RCT | 41 | subacute stroke patients with hemiplegia | 0 | PSHJE (21) | SMA | 64.9 ± 12.2 | 38 |
No PSHJE (20) | 62.3 ± 9.3 | 30 | |||||||
13 | Buesing (2015) | RCT | 50 | Chronic stroke | 3 | PSHJE (25) | SMA | 60 ± 2 | 32 |
No PSHJE (25) | 62 ± 3 | 36 |